Transcription Antibodies
Transcription is the synthesis of an RNA chain which is identical to its DNA coding strand. Single stranded RNA is always complementary to the DNA template. Transcription begins with binding of RNA polymerase to the promoter and then producing a primary transcript and elongation. Transcription ends with termination when RNA polymerase and RNA are released from duplex DNA. Transcription is the first stage and key control point of gene expression. Often RNA can adopt complex secondary structures after transcription.
ProSci has a wide variety of transcription antibodies, including ABT1 antibody (activator of basal transcription 1) and ADPGK antibody (ADP-dependent glucokinase). ProSci antibodies are appropriate for ELISA, western blot, and immunohistochemistry (IHC) applications as noted for each transcription antibody.
| Product Name | Catalog # | App. | Reactivity | Description |
|---|---|---|---|---|
| TADA2L Antibody | 25-406 | E, WB | H | TADA2L (transcriptional adaptor 2 (ADA2 homolog, y |
| TADA2L Antibody | 25-407 | E, WB | H | TADA2L (transcriptional adaptor 2 (ADA2 homolog, y |
| TADA3L Antibody | 28-942 | E, WB | H, M, R, D | TADA3L (transcriptional adaptor 3 (NGG1 homolog, y |
| TADA3L Antibody | 28-941 | E, WB | H, M, R, D, ZF | TADA3L (transcriptional adaptor 3 (NGG1 homolog, y |
| TADA3L Antibody | 27-357 | E, WB, IHC | H, M, R | TADA3L (transcriptional adaptor 3 (NGG1 homolog, y |
| TADA3L Antibody | 25-089 | E, WB | H, M, R | TADA3L (transcriptional adaptor 3 (NGG1 homolog, y |
| TAF1 Antibody | 25-069 | E, WB | H, M, R | TAF1 (TAF1 RNA polymerase II, TATA box binding pro |
| TAF1 Antibody | 27-611 | E, WB | H | TAF1 (TAF1 RNA polymerase II, TATA box binding pro |
| TAF10 Antibody | 27-340 | E, WB | H, M, D | TAF10 (TAF10 RNA polymerase II, TATA box binding p |
| TAF11 Antibody | 27-505 | E, WB | H | TAF11 (TAF11 RNA polymerase II, TATA box binding p |
| TAF15 Antibody | 27-295 | E, WB, IHC | H | TAF15 (TAF15 RNA polymerase II, TATA box binding p |
| TAF15 Antibody | 29-312 | E, WB | H, M | TAF15 (TAF15 RNA polymerase II, TATA box binding p |
| TAF15 Antibody | 27-294 | E, WB | H | TAF15 (TAF15 RNA polymerase II, TATA box binding p |
| TAF1A Antibody | 31-184 | E, WB, IHC | H | TAF1A (TATA box binding protein (TBP)-associated f |
| TAF1A Antibody | 31-183 | E, WB | H | TAF1A (TATA box binding protein (TBP)-associated f |
| TAF1B Antibody | 28-643 | E, WB | M | TAF1A (TATA box binding protein (TBP)-associated f |
| TAF1C Antibody | 28-914 | E, WB | H | TAF1C (TATA box binding protein (TBP)-associated f |
| TAF2 Antibody | 25-136 | E, WB | H, M, R | TAF2 (TAF2 RNA polymerase II, TATA box binding pro |
| TAF3 Antibody | 26-594 | E, WB | H | TAF3 (TAF3 RNA polymerase II, TATA box binding pro |
| TAF5L Antibody | 27-636 | E, WB | H, D | TAF5L (TAF5-like RNA polymerase II, (PCAF)-associa |
| TAF5L Antibody | 31-261 | E, WB | H, M, R | TAF5L (TAF5-like RNA polymerase II, (PCAF)-associa |
| TAF6 Antibody | 28-913 | E, WB | H, M, R, D | TAF6 (TAF6 RNA polymerase II, TATA box binding pro |
| TAF6 Antibody | 28-165 | E, WB, IHC | H, M, R, D | TAF6 (TAF6 RNA polymerase II, TATA box binding pro |
| TAF6L Antibody | 28-948 | E, WB | H, M, R, D | TAF6L (TAF6L RNA polymerase II, TATA box binding p |
| TAF7 Antibody | 31-243 | E, WB, IHC | H, R, D | TAF7 (TAF7 RNA polymerase II, TATA box binding pro |
| TAF7L Antibody | 42-183 | E | H | (IN) TAF7L |
| TAF7L Antibody | 28-759 | E, WB | M | TAF7L (TAF7L RNA polymerase II, TATA box binding p |
| TAF7L Antibody | 28-668 | E, WB | M | TAF7L (TAF7L RNA polymerase II, TATA box binding p |
| TAF8 Antibody | 42-253 | E, WB | H | (IN) TAF8 / TAFII43 |
| TAF9 Antibody | 28-123 | E, WB, IHC | H | TAF9 (TAF9 RNA polymerase II, TATA box binding pro |
| TAL1 Antibody | 31-158 | E, WB | H, D | TAL1 (T-cell acute lymphocytic leukemia 1) |
| TAL1 Antibody | 31-244 | E, WB | H, M, R, D | TAL1 (T-cell acute lymphocytic leukemia 1) |
| TAL1 Antibody | 31-157 | E, WB, IHC | H | TAL1 (T-cell acute lymphocytic leukemia 1) |
| TAL1 Antibody | 31-245 | E, WB | H, M, R, D | TAL1 (T-cell acute lymphocytic leukemia 1) |
| TAL2 Antibody | 25-442 | E, WB | H | TAL2 (T-cell acute lymphocytic leukemia 2) |
| TANK Antibody | 28-865 | E, WB | H | TANK (TRAF family member-associated NFKB activator |
| TARDBP Antibody | 25-292 | E, WB | H, M | TARDBP (TAR DNA binding protein) |
| TARDBP Antibody | 28-975 | E, WB, IHC | H, M, R, D | TARDBP (TAR DNA binding protein) |
| TARDBP Antibody | 28-976 | E, WB, IHC | H, M | TARDBP (TAR DNA binding protein) |
| TBC1D10B Antibody | 28-116 | E, WB | H | TBC1D10B (TBC1 domain family, member 10B) |
| TBP Antibody | 31-246 | E, WB | H, M, R, D, ZF | TBP (TATA box binding protein) |
| TBPL1 Antibody | 28-345 | E, WB, IHC | H, M, R, D | TBPL1 (TBP-like 1) |
| TBX1 Antibody | 27-848 | E, WB, IHC | H, M, R | TBX1 (T-box 1) |
| TBX1 Antibody | 25-137 | E, WB | H | TBX1 (T-box 1) |
| TBX10 Antibody | 27-128 | E, WB | H | TBX10 (T-box 10) |
| TBX10 Antibody | 27-467 | E, WB | H | TBX10 (T-box 10) |
| TBX15 Antibody | 30-316 | E, WB, IHC | H, M, R, D | TBX15 (T-box 15) |
| TBX18 Antibody | 25-398 | E, WB | H, M, R | TBX18 (T-box 18) |
| TBX18 Antibody | 25-348 | E, WB | H, R | TBX18 (T-box 18) |
| TBX19 Antibody | 27-565 | E, WB | H | TBX19 (T-box 19) |

